In contrast, we found that CHRM1 mRNA expression is significantly reduced in human colon neoplasia [4] and Chrm1 ablation in mouse models negates the anti-neoplastic effects of Chrm3 ablation [5]; that is, Chrm1/M1R expression appears to protect against colon cancer. This evidence concerns the gene CHRM3 and malignant colon neoplasm.